NASDAQ · Dividend

NovoCure Limited (NVCR) Dividend

$11.14 NASDAQ: NVCR Market Cap $1.30B

Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)

MetricValue
Dividend YieldNone
Indicated Annual Dividend—
Payout Ratio—
FCF Yield-5.50%
Current Price$11.14

Dividend Analysis

NovoCure Limited (NVCR) does not currently pay a dividend, based on the latest available data. Companies that do not pay dividends may use earnings for reinvestment, acquisitions, share buybacks, or debt repayment instead.

Free cash flow yield of -5.50% is below the 0.00% dividend yield, so the dividend is not fully covered by free cash flow at the current price.

Dividend yield against peers

NovoCure Limited has the lowest dividend yield of the 9 companies compared here.

CompanyYieldP/EPrice
Becton, Dickinson and Company (BDX)2.01%50.89$215.42
West Pharmaceutical Services, Inc. (WST)0.26%45.37$414.12
Baxter International Inc. (BAX)0.16%—$25.76
Medline Inc. (MDLN)0.00%62.75$37.68
Solventum Corporation (SOLV)0.00%99.57$86.06
The Cooper Companies, Inc. (COO)0.00%20.32$60.72
Repligen Corporation (RGEN)0.00%—$162.18
Avantor, Inc. (AVTR)0.00%31.15$15.18
NovoCure Limited (NVCR)0.00%-13.78$11.14

NovoCure Limited (NVCR) dividend — frequently asked questions

Does NovoCure Limited (NVCR) pay a dividend?

No, NovoCure Limited (NVCR) does not currently pay a dividend.

Dividend yields of other Medical - Instruments & Supplies stocks

BDX yield 2.01%WST yield 0.26%BAX yield 0.16%ATR yield 1.39%All Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
NVCR Overview NVCR Financials Screen Dividend Stocks

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.